HTA and Reimbursement Status of Metastatic HormoneSensitive Prostate Cancer, Non-Metastatic Castration-Resistant Prostate Cancer, and Metastatic Castration-Resistant Prostate Cancer Treatments in Europe: A Patient Access Landscape Review.
J Health Econ Outcomes Res
; 10(1): 102-110, 2023.
Article
em En
| MEDLINE
| ID: mdl-37366384
Texto completo:
1
Base de dados:
MEDLINE
Tipo de estudo:
Diagnostic_studies
/
Health_technology_assessment
/
Prognostic_studies
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article